VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 113 filers reported holding VERASTEM INC in Q1 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $666,000 | -1.9% | 225,017 | +11.3% | 0.00% | 0.0% |
| Q4 2018 | $679,000 | -90.2% | 202,092 | -79.0% | 0.00% | -75.0% |
| Q3 2018 | $6,964,000 | +900.6% | 960,584 | +849.9% | 0.00% | +300.0% |
| Q2 2018 | $696,000 | +527.0% | 101,128 | +44.3% | 0.00% | – |
| Q1 2016 | $111,000 | +30.6% | 70,082 | +53.4% | 0.00% | – |
| Q4 2015 | $85,000 | +1.2% | 45,691 | -3.0% | 0.00% | – |
| Q3 2015 | $84,000 | -76.3% | 47,105 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $355,000 | -2.7% | 47,105 | +31.3% | 0.00% | 0.0% |
| Q1 2015 | $365,000 | +69.8% | 35,886 | +52.4% | 0.00% | – |
| Q4 2014 | $215,000 | +7.0% | 23,543 | 0.0% | 0.00% | – |
| Q3 2014 | $201,000 | -25.6% | 23,543 | -21.1% | 0.00% | -100.0% |
| Q2 2014 | $270,000 | -6.2% | 29,833 | +11.6% | 0.00% | 0.0% |
| Q1 2014 | $288,000 | +12.9% | 26,722 | +19.7% | 0.00% | 0.0% |
| Q4 2013 | $255,000 | -8.3% | 22,332 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $278,000 | +6.1% | 22,332 | +18.2% | 0.00% | 0.0% |
| Q2 2013 | $262,000 | – | 18,891 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |